Search

Your search keyword '"Morady F"' showing total 1,017 results
Start Over Author "Morady F"
1,017 results on '"Morady F"'

5. Irish Cardiac Society Proceedings of meeting held 23rd–24th November, 1990

Author

Stanton, A., Kilfeather, S., O’Brien, E., O’Malley, K., Donnelly, M. D. I., Batchelor, Y., McAleer, B., Dalton, G., Turkington, E., Williams, J. R., Varma, M. P. S., Okeefe, S., Redehan, C., Keane, P., Daly, K., Rollins, N. C., Mulholland, H. C., Craig, B., McCann, H. A., Walsh, T. P., Kittrick, H. C., Keelan, E., Codd, M., McCarthy, J., McCarthy, C., Sugrue, D. D., O’Donnell, A. F., Lonergan, M., Daly, L., McGovem, E. M., Keelan, E., Sugrue, D. D., Murphy, J. G., Schwartz, R. S., Garratt, K., Holmes, D. R., Foley, B., Sheehan, R., Kinsella, A., Gearty, G., Walsh, M., Crean, P., Glazier, J. J., Piessens, J., Stammen, F., Vergauwen, V., De Geest, H., Willems, J. L., Quigley, P. J., Ohman, M., Smith, J. E., Stack, R. S., Glazier, J. J., Rickards, A. F., McFadden, E., Clarke, J., Davies, G., Maseri, A., Dickey, W., Adgey, A. A. J., Chew, E. W., Morton, P., Murtagh, J. G., Scott, M. E., O’Keeffe, D. B., O’Murchu, B., Miller, M., Burnett, J. C., Rose, M., Gibney, M., Gearty, G., Crean, P., O’Connor, P., Walsh, M., O’Keeffe, S., Grimes, H., Finn, J., McMurrough, P., Daly, K., Roberts, M. J. D., Pruvis, J. A., McNeill, A. J., Trouton, T. J., Dalzell, T. G. W. N., Dalzell, G. W. N., Flannery, D. J., Wilson, C. M., Patterson, G. C., Webb, S. W., Campbell, N. P. S., Khan, M. M., Molajo, A. O., Adgey, A. A. J., McClements, B. M., Trouton, T. G., Dalzell, G. W. N., Campbell, N. P. S., Webb, S. W., Khan, M. M., Patterson, G. C., Wilson, C. M., Adgey, A. A. J., Flannery, D. J., O’Neill, A. J., Adgey, J., Campbell, N. P. S., Walsh, K., Sreeram, N., Franks, R., Arnold, R., Lonergan, M., Daly, L., Graham, I., Hurley, J., Neligan, M. C., Wood, A. E., de Buitleir, M., Sousa, J., Calkins, H., Rosenheck, S., Langberg, J., Morady, F., Maghur, H. A., Wood, A. E., Neligan, M. C., Murphy, J. G., Gersh, B. J., Oslizok, P., Allen, M., Gillette, R. N., Oslizlok, P., Allen, M., Case, C., Gillette, P. C., Duff, D., Mulholland, C., Craig, B., Mulholland, C., and Duff, D.

Published
1991
Full Text
View/download PDF

7. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society

Author

Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, Haines DE, Haissaguerre M, Iesaka Y, Jackman W, Jais P, Kottkamp H, Kuck KH, Lindsay BD, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Natale A, Pappone C, Prystowsky E, Raviele A, Ruskin JN, Shemin RJ, Heart Rhythm Society, European Heart Rhythm Association, European Cardiac Arrhythmia Society, American College of Cardiology, American Heart Association, Society of Thoracic Surgeons, Calkins, H, Brugada, J, Packer, Dl, Cappato, R, Chen, Sa, Crijns, Hj, Damiano RJ, Jr, Davies, Dw, Haines, De, Haissaguerre, M, Iesaka, Y, Jackman, W, Jais, P, Kottkamp, H, Kuck, Kh, Lindsay, Bd, Marchlinski, Fe, Mccarthy, Pm, Mont, Jl, Morady, F, Nademanee, K, Natale, A, Pappone, C, Prystowsky, E, Raviele, A, Ruskin, Jn, Shemin, Rj, Heart Rhythm, Society, European Heart Rhythm, Association, European Cardiac Arrhythmia, Society, American College of, Cardiology, American Heart, Association, Society of Thoracic, Surgeons, Crijns, Hjg, and Damiano Jr, Rj

Subjects
Diagnostic Imaging, medicine.medical_specialty, Statement (logic), medicine.medical_treatment, Catheter ablation, Electrocardiography, Postoperative Complications, Heart Conduction System, Recurrence, Thromboembolism, Physiology (medical), Atrial Fibrillation, Health care, medicine, Humans, Heart Atria, Intensive care medicine, Societies, Medical, Clinical Trials as Topic, Task force, business.industry, General surgery, Health Policy, Patient Selection, Body Surface Potential Mapping, Expert consensus, Cardiac arrhythmia, Atrial fibrillation, Prognosis, medicine.disease, Ablation, United States, Heart Rhythm, Electrophysiology, Europe, Catheter, Pulmonary Veins, Catheter Ablation, Electrophysiologic Techniques, Cardiac, Cardiology and Cardiovascular Medicine, business, Anti-Arrhythmia Agents, Personnel policy, Surgical ablation
Abstract

During the past decade, catheter ablation of atrial fibrillation (AF) has evolved rapidly from a highly experimental unproven procedure, to its current status as a commonly performed ablation procedure in many major hospitals throughout the world. Surgical ablation of AF, using either standard or minimally invasive techniques, is also performed in many major hospitals throughout the world. The purpose of this Consensus Statement is to provide a state-of-the-art review of the field of catheter and surgical ablation of AF, and to report the findings of a Task Force, convened by the Heart Rhythm Society and charged with defining the indications, techniques, and outcomes of this procedure. The Heart Rhythm Society was pleased to develop this Consensus Statement in partnership with the European Heart Rhythm Association and the European Cardiac Arrhythmia Society. This statement summarizes the opinion of the Task Force members based on their own experience in treating patients, as well as a review of the literature, and is directed to all health care professionals who are involved in the care of patients with AF, particularly those who are undergoing or are being considered for catheter or surgical ablation procedures for AF. This statement is not intended to recommend or promote catheter ablation of AF. Rather the ultimate judgment regarding care of a particular patient must be made by the health care provider and patient in light of all the circumstances presented by that patient. In writing a “consensus” document, it is recognized that consensus does not mean that there was complete agreement among all Task Force members. We attempted to identify those aspects of AF ablation for which a true “consensus” could be identified ( Tables 1 and 2 ). Surveys of the entire Task Force were used to identify these areas of consensus. The main objective of this document is …

Published
2007

8. The authors reply [11]

Author

Oral H., Pappone C., Morady F., Oral, H., Pappone, C., and Morady, F.

Published
2006

10. Poster Session 1: Ablation of SVT and VT

Author

De Groot, N. M. S., primary, Atary, J. Z., additional, Blom, N. A., additional, Van Kuijk, J. P., additional, Schalij, M. J., additional, Tomaske, M., additional, Candinas, R., additional, Weiss, M., additional, Bauersfeld, U., additional, Fassa, A.- A., additional, Ashrafpoor, G., additional, Sunthorn, H., additional, Burri, H., additional, Gentil-Baron, P., additional, Shah, D., additional, Wijnmaalen, A. P., additional, Delgado, V., additional, Holman, E. R., additional, Bax, J. J., additional, Zeppenfeld, K., additional, Kuhne, M., additional, Oral, H., additional, Morady, F., additional, Bogun, F., additional, Schwagten, B., additional, Szili-Torok, T., additional, Knops, P., additional, Kimman, G., additional, Thornton, A., additional, Jordaens, L., additional, Satomi, K., additional, Roland, T., additional, Kamakura, S., additional, Kuck, K., additional, Ouyang, F., additional, Nowak, S., additional, Wnuk-Wojnar, A. M., additional, Hoffmann, A., additional, Czerwinski, C., additional, Szydlo, K., additional, Rybicka-Musialik, A., additional, Wozniak-Skowerska, I., additional, Trusz-Gluza, M., additional, Krynski, T., additional, Stec, S. M., additional, Hachiya, H., additional, Hirao, K., additional, Sasaki, T., additional, Higuchi, K., additional, Isobe, M., additional, Etsadashvili, K., additional, Hintringer, F., additional, Stuehlinger, X., additional, Berger, T., additional, Dichtl, W., additional, Roithinger, F. X., additional, Pachinger, O., additional, Stuehlinger, M., additional, Tanno, K., additional, Onuki, T., additional, Minoura, Y., additional, Kawamura, M., additional, Asano, T., additional, Kobayashi, Y., additional, Bonet, A., additional, Merce Klein, J., additional, De Castro, R., additional, Valdovinos, P., additional, Colomer, I., additional, Garcia, M. I., additional, Serrano, I., additional, Bardaji, A., additional, Peichl, P., additional, Cihak, R., additional, Polasek, R., additional, Kucera, P., additional, Bytesnik, J., additional, Kautzner, J., additional, Schlueter, S., additional, Grebe, O., additional, Vester, E. V., additional, Maury, P., additional, Fourcade, J., additional, Duparc, A., additional, Hebrard, A., additional, Mondoly, P., additional, Rollin, A., additional, Rumeau, P., additional, Delay, M., additional, De Boeck, B. W. L., additional, Teske, A. J., additional, Mohamed Hoesein, F. A. A., additional, Van Driel, V. J. H., additional, Loh, P., additional, Cramer, M. J. M., additional, Prinzen, F. W., additional, Doevendans, P. A. F., additional, Pokushalov, E., additional, Romanov, A., additional, Turov, A., additional, Shugaev, P., additional, Artemenko, S., additional, Shirokova, N., additional, Richter, B., additional, Gwechenberger, M., additional, Socas, A., additional, Zorn, G., additional, Albinni, S., additional, Wojta, J., additional, Binder, T., additional, Goessinger, H., additional, Kettering, K., additional, Mollnau, H., additional, Gramley, F., additional, Weiss, C., additional, Berkowitsch, A., additional, Neumann, T., additional, Kuniss, M., additional, Zaltsberg, S., additional, Wojcik, M., additional, Pitschner, H. F., additional, Wichterle, D., additional, Peca, M., additional, Bulkova, V., additional, Suzuki, A., additional, Yamauchi, Y., additional, Okada, H., additional, Obayashi, T., additional, Sekiguchi, Y., additional, Aonuma, K., additional, Zoppo, F., additional, Bertaglia, E., additional, Zerbo, F., additional, Brandolino, G., additional, Bacchiega, E., additional, Lickfett, L., additional, Bellmann, B., additional, Linhart, M., additional, Schrickel, J. W., additional, Lewalter, T., additional, Schwab, J. O., additional, Nickenig, G., additional, Mittmann-Braun, E. L., additional, Dabrowski, P., additional, Kozluk, E., additional, Stefanczyk, P., additional, Kleinrok, A., additional, Opolski, G., additional, Andronache, M., additional, Abdelaal, A., additional, Magnin-Poull, I., additional, Cedano, J., additional, Groben, L., additional, Mandry, D., additional, Aliot, E., additional, De Chillou, C., additional, Mulder, A. A. W., additional, Wijffels, M. C. E. F., additional, Wever, E. F. D., additional, Boersma, L. V. A., additional, Manfai, B., additional, Faludi, R., additional, Fodi, E., additional, Rausch, P., additional, Simor, T., additional, Sciarra, L., additional, Rebecchi, M., additional, De Ruvo, E., additional, De Luca, L., additional, Zuccaro, L. M., additional, Fagagnini, A., additional, Delise, P., additional, Calo, L., additional, Mikhaylov, E., additional, Van Belle, Y., additional, Janse, P., additional, Lebedev, D., additional, Kanidieva, A., additional, Patel, D., additional, Shaheen, M., additional, Sonne, K., additional, Mohanty, P., additional, Di-Biase, L., additional, Popova, L., additional, Burkhardt, D., additional, Natale, A., additional, Mccann, C. J., additional, Gal, B., additional, Goethals, P., additional, Peychev, P., additional, Geelen, P., additional, Vatasescu, R.- G., additional, Iorgulescu, C., additional, Ieremciuc, I., additional, Alexandru, R., additional, Dorobantu, M., additional, Insulander, P., additional, Bastani, H., additional, Braunschweig, F., additional, Jensen-Urstad, M., additional, Schwieler, J., additional, Tabrizi, F., additional, Kenneback, G., additional, Foldesi, C. S. A. B. A., additional, Kardos, A., additional, Mihalcz, A., additional, Abraham, P. A. L., additional, Som, Z. O. L. T. A. N., additional, Borbola, J. O. Z. S. E. F., additional, Vanyi, J. O. Z. S. E. F., additional, Szili-Torok, T. A. M. A. S., additional, Pastor Fuentes, A., additional, Nunez, A., additional, Tur, N., additional, Berzal, B., additional, G Cosio, F., additional, Mujovic, N., additional, Grujic, M., additional, Mrdja, S., additional, Kocijancic, A., additional, Potpara, T., additional, Polovina, M., additional, Vujisic-Tesic, B., additional, Petrovic, M., additional, Hayashi, T., additional, Furukawa, T., additional, Kawabata, M., additional, Lavalle, C., additional, Ficili, S., additional, Galeazzi, M., additional, Russo, M., additional, Pandozi, A., additional, Pandozi, C., additional, Venditti, F., additional, Santini, M., additional, Pavlikova, K., additional, Psenicka, M., additional, Anger, Z., additional, Linhart, A., additional, Narten, A., additional, Gamelin, A., additional, Mittag, J., additional, Raffa, S., additional, Geller, J.- C., additional, Mocini, D., additional, Groenveld, H. F., additional, Rienstra, M., additional, Van Den Berg, M. P., additional, Hillege, H. L., additional, Van Veldhuisen, D. J., additional, Van Gelder, I. C., additional, Morani, G., additional, Manica, A., additional, Angheben, C., additional, Cicoira, M. A., additional, Pozzani, L., additional, Tomasi, L., additional, Zanotto, G., additional, Vassanelli, C., additional, Ahmed, S., additional, Ranchor, A. V., additional, and Wiesfeld, A. C. P., additional

Published
2009
Full Text
View/download PDF

11. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation

Author

Calkins, H., primary, Brugada, J., additional, Packer, D. L., additional, Cappato, R., additional, Chen, S.-A., additional, Crijns, H. J.G., additional, Damiano, R. J., additional, Davies, D. W., additional, Haines, D. E., additional, Haissaguerre, M., additional, Iesaka, Y., additional, Jackman, W., additional, Jais, P., additional, Kottkamp, H., additional, Kuck, K. H., additional, Lindsay, B. D., additional, Marchlinski, F. E., additional, McCarthy, P. M., additional, Mont, J. L., additional, Morady, F., additional, Nademanee, K., additional, Natale, A., additional, Pappone, C., additional, Prystowsky, E., additional, Raviele, A., additional, Ruskin, J. N., additional, and Shemin, R. J., additional

Published
2008
Full Text
View/download PDF

14. Effect of a change in rate on atrial repolarization

Author

Goyal, R., primary, Syed, Z.A., additional, Mukhopadhyay, P.S., additional, Tran, B.C., additional, Souza, J., additional, Zivin, A., additional, Pelosi, F., additional, Flomming, M., additional, Knight, B.P., additional, Man, K.C., additional, Strickberger, S.A., additional, and Morady, F., additional

Published
1998
Full Text
View/download PDF

27. Relation of symptoms and symptom duration to premature ventricular complex-induced cardiomyopathy.

Author

Yokokawa M, Kim HM, Good E, Chugh A, Pelosi F Jr, Alguire C, Armstrong W, Crawford T, Jongnarangsin K, Oral H, Morady F, Bogun F, Yokokawa, Miki, Kim, Hyungjin Myra, Good, Eric, Chugh, Aman, Pelosi, Frank Jr, Alguire, Craig, Armstrong, William, and Crawford, Thomas

Abstract

Background: Frequent idiopathic premature ventricular complexes (PVCs) can result in a reversible form of cardiomyopathy. In this study, the determinants of PVC-induced left ventricular (LV) dysfunction were assessed. Methods: The subjects of this study were 241 consecutive patients (115 men [48%], mean age 48 ± 14 years) referred for ablation of frequent PVCs. One hundred eighty patients (75%) experienced palpitations and 61 (25%) did not. The PVC burden was determined by 24-hour Holter monitoring, and echocardiograms were performed to assess LV function. An LV ejection fraction of <50% was considered abnormal. Results: LV ejection fraction (mean 0.36 ± 0.09) was present in 76 of 241 patients (32%). There was a higher prevalence of males among the patients with PVC cardiomyopathy compared to patients with normal LV function (51/76 [67%] vs 64/165 [39%]; P <.0001). The mean PVC burden was significantly higher in patients with PVC cardiomyopathy than in patients with normal LV function (28% ± 12% vs 15% ± 13%; P <.0001). Among symptomatic patients, those with cardiomyopathy had a significantly longer duration of palpitations (135 ± 118 months) compared with patients with normal LV function (35 ± 52 months; P <.0001). The proportion of asymptomatic patients was significantly higher in the presence of cardiomyopathy (36/76, 47%) than in normal LV function (25/165, 15%; P <.0001). Symptom duration of 30 to 60 months, symptom duration >60 months, the absence of symptoms, and the PVC burden in asymptomatic patients were independent predictors of impaired LV function (adjusted odds ratio [95% confidence interval]: 4.0 [1.1-14.4], 20.1 [6.3-64.1], 13.1 [4.1-37.8], and 2.1 [1.2-3.6], respectively). Conclusions: The duration of palpitations and the absence of symptoms are independently associated with PVC-induced cardiomyopathy. [ABSTRACT FROM AUTHOR]

Published
2012
Full Text
View/download PDF

28. A critical decrease in dominant frequency and clinical outcome after catheter ablation of persistent atrial fibrillation.

Author

Yoshida K, Chugh A, Good E, Crawford T, Myles J, Veerareddy S, Billakanty S, Wong WS, Ebinger M, Pelosi F, Jongnarangsin K, Bogun F, Morady F, Oral H, Yoshida, Kentaro, Chugh, Aman, Good, Eric, Crawford, Thomas, Myles, James, and Veerareddy, Srikar

Abstract

Background: Termination of persistent atrial fibrillation (AF) by radiofrequency ablation (RFA) is associated with a high probability of freedom from AF but requires extensive ablation and long procedure times.Objective: The purpose of this study was to determine whether a critical decrease in the dominant frequency (DF) of AF is a sufficient endpoint for RFA of persistent AF.Methods: Antral pulmonary vein isolation (APVI) followed by RFA of complex fractionated atrial electrograms (CFAEs) in the atria and coronary sinus was performed in 100 consecutive patients with persistent AF. The DF of AF in lead V1 and in the coronary sinus was determined by fast Fourier transform (FFT) analysis at baseline and before termination of AF to identify a critical decrease in DF predictive of sinus rhythm after RFA.Results: A > or =11% decrease in DF had the highest accuracy in predicting freedom from atrial arrhythmias, with a sensitivity of 0.71 and a specificity of 0.82 (P <.001). At a mean follow-up of 14 +/- 3 months after one ablation procedure, sinus rhythm was maintained off antiarrhythmic drugs in 8/35 (23%) and 20/26 (77%) of patients with a <11% and > or =11% decrease in DF, respectively (P <.001). Sinus rhythm was maintained in 24/39 patients (62%) in whom RFA terminated AF. The duration of RFA and total procedure time were longer in patients with AF termination (95 +/- 23 and 358 +/- 87 minutes) than in patients with a <11% decrease in the DF (77 +/- 16 and 293 +/- 70 minutes) or > or =11% decrease in DF (80 +/- 17 and 289 +/- 73 minutes), respectively (P <.01). Among the variables of age, gender, left atrial diameter, duration of AF, left ventricular ejection fraction, duration of RFA, a > or =11% decrease in DF, and termination of AF, a > or =11% decrease in DF (odds ratio = 9.89, 95% confidence interval [CI] 2.84-34.47) and termination during RFA (OR = 4.38, 95% CI 1.50-12.80) were the only independent predictors of freedom from recurrent atrial arrhythmias.Conclusion: In a retrospective analysis of consecutive patients with persistent AF, a decrease in the DF of AF by 11% in response to APVI and ablation of CFAEs was associated with a probability of maintaining sinus rhythm that was similar to that when RFA terminates AF. [ABSTRACT FROM AUTHOR]

Published
2010
Full Text
View/download PDF

31. Time to cardioversion of recurrent atrial arrhythmias after cathetic ablation of atrial fibrillation and long-term clinical outcome.

Author

Baman TS, Gupta SK, Billakanty SR, Ilg KJ, Good E, Crawford T, Jongnarangsin K, Ebinger M, Pelosi F Jr., Bogun F, Chugh A, Morady F, and Oral H

Abstract

Introduction: It is unclear whether early restoration of sinus rhythm in patientswith persistent atrial arrhythmias after catheter ablation of atrial fibrillation (AF) facilitates reverse atrial remodeling and promotes long-term maintenance of sinus rhythm. The purpose of this study was to determine the relationship between the time to restoration of sinus rhythm after a recurrence of an atrial arrhythmia and long-term maintenance of sinus rhythm after radiofrequency catheter ablation of AF. Methods and Results: Radiofrequency catheter ablation was performed in 384 consecutive patients (age 60 ± 9 years) for paroxysmal (215 patients) or persistent AF (169 patients). Transthoracic cardioversion was performed in all 93 patients (24%) who presented with a persistent atrial arrhythmia: AF (n = 74) or atrial flutter (n = 19) at a mean of 51 ± 53 days from the recurrence of atrial arrhythmia and 88 ± 72 days from the ablation procedure. At a mean of 16 ± 10 months after the ablation procedure, 25 of 93 patients (27%) who underwent cardioversion were in sinus rhythm without antiarrhythmic therapy. Among the 46 patients who underwent cardioversion at

Published
2009
Full Text
View/download PDF

36. Techniques and technology. Ablation of ventricular tachycardia in patients with nonischemic cardiomyopathy.

Author

Bogun F and Morady F

Abstract

Mapping and ablation of ventricular tachycardia (VT) in patients with nonischemic cardiomyopathy can be challenging. In this article, we describe the approach to VT in patients with nonischemic cardiomyopathy that we use at the University of Michigan. Imaging, especially with delayed enhanced cardiac magnetic resonance imaging, plays a central role in planning a mapping and ablation procedure. During the mapping procedure, pace-mapping in conjunction with voltage maps focusing on areas with isolated potentials helps to identify scar areas that are critical for VT in these patients. [ABSTRACT FROM AUTHOR]

Published
2008
Full Text
View/download PDF

43. CRT-D therapy in patients with left ventricular dysfunction and atrial fibrillation.

Author

Pelosi F Jr., Morady F, Pelosi, Frank Jr, and Morady, Fred

Abstract

The number of patients with atrial fibrillation and congestive heart failure has steadily increased in the United States. The presence of atrial fibrillation increases morbidity and mortality for patients with left ventricular dysfunction. The emergence of cardiac resynchronization therapy to improve symptoms and survival from congestive heart failure may provide benefits for those with atrial fibrillation; we review the pathophysiology of atrial fibrillation in the presence of left ventricular dysfunction and the promise of cardiac resynchronization therapy to improve symptoms for the for these patients. [ABSTRACT FROM AUTHOR]

Published
2005

Catalog

Books, media, physical & digital resources
See catalog results